Evidence map›Paper›PMID 30999583›Full record

ReviewAntioxidants (Basel, Switzerland)2019

Is There A Role for Abscisic Acid, A Proven Anti-Inflammatory Agent, in the Treatment of Ischemic Retinopathies?

Pablo Baliño, Aurelio Gómez-Cadenas, Daniel López-Malo, Francisco Javier Romero, María Muriach

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Amino acid motifs for the identification of novel protein interactants.Computational and structural biotechnology journal · 2023
    Review
  7. The Effects of Abscisic Acid on Angiogenesis in Both ex vivo and in vivo Assays.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antioxidants and Retinal Diseases.Antioxidants (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pablo BaliñoUnitat predepartamental de Medicina, Universitat Jaume I, 12071 Castellón de la Plana, Spain. balino@uji.es.
Aurelio Gómez-CadenasDepartament de Ciències Agràries i del Medi Natural, Universitat Jaume I, 12071 Castellón de la Plana, Spain. aurelio.gomez@uji.es.
Daniel López-MaloDepartamento de Ciencias Biomédicas, Universidad Europea de Valencia, 46010 Valencia, Spain. daniel.lopez2@universidadeuropea.es.ORCID 0000-0003-2661-7570
Francisco Javier RomeroDepartamento de Ciencias Biomédicas, Universidad Europea de Valencia, 46010 Valencia, Spain. franciscojavier.romero@universidadeuropea.es.ORCID 0000-0001-8701-5907
María MuriachUniversitat Jaume I, Unitat predepartamental de Medicina, Avda/Sos Baynat, S/N, 12071 Castellón de la Plana, Spain. muriach@uji.es.
Universitat Jaume I · ESUniversidad Europea de Madrid · ES

Funding

Generalitat Valenciana PROMETEO/2016/094; GV/2017/096Universitat Jaume I UJI-A2016-03
6 · The paper itself

Abstract

Ischemic retinopathies (IRs) are the main cause of severe visual impairment and sight loss, and are characterized by loss of blood vessels, accompanied by hypoxia, and neovascularization. Actual therapies, based on anti-vascular endothelial growth factor (VEGF) strategies, antioxidants or anti-inflammatory therapies are only partially effective or show some adverse side effects. Abscisic acid (ABA) is a phytohormone present in vegetables and fruits that can be naturally supplied by the dietary intake and has been previously studied for its benefits to human health. It has been demonstrated that ABA plays a key role in glucose metabolism, inflammation, memory and tumor growth. This review focuses on a novel and promising role of ABA as a potential modulator of angiogenesis, oxidative status and inflammatory processes in the retina, which are the most predominant characteristics of the IRs. Thus, this nutraceutical compound might shed some light in new therapeutic strategies focused in the prevention or amelioration of IRs-derived pathologies.

Indexed as

abscisic acidangiogenesisinflammationischemic retinopathyoxidative stress

Identifiers

PMID30999583
PMCPMC6523110
OpenAlexW2935936425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.